Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $146.8200 (1.26%) ($146.8200 - $146.8200) on Tue. Apr. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.23% (three month average) | RSI | 48 | Latest Price | $146.8200(1.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND advances 0.1% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.615% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.615% (StdDev 5.23%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $147.18(0.25%) | Resistance Level | $153.8 | 5 Day Moving Average | $150.79(-2.63%) | 10 Day Moving Average | $151.71(-3.22%) | 20 Day Moving Average | $153.8(-4.54%) | To recent high | -32% | To recent low | 32.2% | Market Cap | $2.36b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |